Torrent Pharmaceuticals Limited (Torrent) is a pharmaceutical company. It is engaged in developing and marketing new formulations in various therapeutic areas. It manufactures and sells branded-generic and unbranded-generic pharmaceutical products. The company has operations in Asia Pacific, Africa, Europe and the Americas. The company operates through a single segment, pharmaceuticals. The company's pharmaceuticals segment is engaged in the manufacture of branded formulations. The company's therapeutic areas include cardiovascular, gastrointestinal, central nervous system (CNS), anti-infective, pain management and anti-diabetics. Torrent has a formulations manufacturing facility at Baddi in Himachal Pradesh, India. Its Baddi facility has a capacity to manufacture 4.8 billion dosage forms per annum. The company's Indrad plant, Gujarat, India has a capacity to manufacture 5,000 million / annum formulations - tablets, 500 million / annum formulations - capsules, 26 million /annum formulations - vials and 45,000 kg (kilogram) of bulk drugs/API (active pharmaceutical ingredient). API manufactured at Indrad Plant and Baddi Plant includes Nicorandil, Risperidone, Venlafaxine Hydrochloride, Ropinarole Hydrochloride, Duloxetine Hydrochloride, Ormeloxifen Hydrochloride, Nebivolol Hydrochloride, Lamotrigine, Sertraline Hydrochloride and Clopidogrel bisulphate. The company also has a formulation facility at Sikkim, located around 20 kilometers from Gangtok. Its Sikkim plant manufactures oral dosage forms and has a capacity to manufacture 3.9 billion dosage forms per annum primarily for domestic markets. Torrent operates through sales and marketing divisions structured on therapeutic areas. It has around 15 sales and marketing divisions: Prima, Vista, Sparsh, Sensa, Mind, Axon, Neuron, Psycan CnD, Psycan, Azuca, Delta, Oncology, B Well, Uno Spirit and Nephro. The company exports its products to more than 40 countries around the world with over 1,200 product registrations. The company's international business is divided into the following zones- the US, Latin America, Russia and commonwealth of independent states (CIS), Canada, the UK, Western Europe and central Eastern Europe (CEE), and rest of the world (ROW). Torrent's subsidiaries include Torrent Pharma Canada Inc., Zyg Pharma Private Limited, Torrent Pharma GmbH, Torrent Pharma Philippines Inc., Laboratories Torrent (Malaysia) Sdn Bhd and Torrent Pharma (UK) Ltd.
Scope of the Report
-- About the Company - Historical Details, Current Ownership Structure and basic overview of Torrent Pharmaceuticals Limited in terms of revenue, net income, and operating income.
-- Financials - Details about Torrent Pharmaceuticals Limited listing status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.
-- Products / Services - Listing of the company’s entire portfolio along with description of individual products / services providing a clear picture of their target audience.
-- Company SWOT Analysis - Outlines Torrent Pharmaceuticals Limited’s strengths, weaknesses, and opportunities and threats facing the company.
-- Recent Developments - Showcases Torrent Pharmaceuticals Limited’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.
-- Strategic Evaluation - Provides an overview of Torrent Pharmaceuticals Limited’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.
-- Technology Landscape - Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken buy the company at present along with outlook.
Key Questions Answered
-- What domain does Torrent Pharmaceuticals Limited operate and what are key points about it?
-- What is the product / service portfolio of Torrent Pharmaceuticals Limited?
-- How has Torrent Pharmaceuticals Limited performed financially from the 2013?
-- How does Torrent Pharmaceuticals Limited rank among its peers in terms of revenue and market share?
-- What are Torrent Pharmaceuticals Limited strengths and weaknesses and what opportunities and threats does it face?
-- What are Torrent Pharmaceuticals Limited’s main growth strategies and how successful has the company been at implementing them?
-- What is the in-house technical capability of Torrent Pharmaceuticals Limited? Where does it procure / outsource it?
Reasons to buy
-- Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own
-- Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at very competitive cost
-- 12 hour delivery time fulfilling your urgent requests as per your requirement
-- On-demand customization options that can completely cater to your needs by focusing the report onto given specifics
1. About the Company
1.1 History and Basic Facts
1.2 Ownership Structure and Key Executives
1.3 Head Office
1.4 Other Locations & Subsidiaries
1.5 List of Competitors
1.6 Employee Count & Distribution
2.1 Company Type (Listed / Unlisted)
2.2 Annual Statements
2.3 Key Financial Highlights
2.4 Region-wise Breakdown
3. Product / Services
4. SWOT Analysis
4.1 SWOT Overview
5. Recent Developments
5.1 Mergers & Acquisitions
5.2 Partnerships, Collaborations & Joint Ventures
5.3 New Product Launches
5.4 Business Expansion / Divestment
6. Strategic Evaluation
6.1 Corporate Strategy
6.2 Legal Issues
6.3 Analyst Outlook
7. Technology Landscape
-- 7.1.1 Industry Snapshot
-- 7.1.2 IT Spend
-- 7.1.3 Key Information Technology Trends
-- 7.2.1 IT Overview
-- 7.2.2 Key IT Technologies
-- 7.2.3 Recent IT Initiatives
-- 7.2.4 IT Outsourcing Engagements
-- 7.2.5 Key IT Management
-- 7.2.6 CIO/CTO Profile
-- About Us
-- Contact Us
Fig.1: Company Snapshot
Fig.2: Locations Listing on Map
Table.1: Ownership Structure
Table.2: List of Competitors
Table.3: Annual Statements
Table.4: Key Financial Highlights
Table.5: Region-wise Breakdown
Table.6: Product/Services Overview
Table.7: Mergers & Acquisitions
Table.8: Partnerships, Collaborations & Joint Ventures
Table.9: New Product Launches
Table.10: Business Expansion / Divestment
Table 11: IT Budgets
Table 12: Key IT Management (CIO / CTO)
Table 13: IT Deals undertaken in the past years